---
figid: PMC8037590__cancers-13-01538-g001
figtitle: PI3K and MAPK signalling pathways
organisms:
- NA
pmcid: PMC8037590
filename: cancers-13-01538-g001.jpg
figlink: pmc/articles/PMC8037590/figure/cancers-13-01538-f001/
number: F1
caption: The PI3K and MAPK signalling pathways. Growth factors and other external
  signalling molecules stimulate the activation of the PI3K and MAPK pathways through
  receptor tyrosine kinase (RTK) phosphorylation at the cell membrane. Activated RTKs
  recruit molecules bearing phosphotyrosine-binding (PTB) or Src homology-2 (SH2)
  domains, such as IRS or p85, respectively. For PI3K enzymes, the binding of the
  p85 subunit activates the catalytic function of p110, prompting the phosphorylation
  of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) to phosphatidylinositol 3,4,5-trisphosphate
  (PI(3,4,5)P3). PI(3,4,5)P3, a prominent second messenger in cell signalling, accumulates
  at the cell membrane attracting molecules with pleckstrin-homology (PH) domains,
  primarily phosphoinositide-dependent protein kinase 1 (PDK1) and the AKT serine/threonine
  kinase family (protein kinase B/PKB). PDK1 partially activates AKT at threonine
  308 through phosphorylation, with full activation enabled by serine 473 phosphorylation
  via the mammalian target of rapamycin (mTOR) complex 2 (mTORC2). AKT targets various
  proteins in order to alter major signalling pathways within the cell. These include
  prosurvival pathways (BIM, BAX, BAD, BCL-2, MDM2 and FoxO1), cell cycle progression
  and glucose metabolism (p27, GSK3 and AS160), and cellular proliferation and protein
  synthesis (TSC2). Another prominent effector targeted downstream in the PI3K pathway
  is mTOR complex 1 (mTORC1), which has been shown to regulate cellular growth and
  metabolism, amongst other processes. In particular, mTORC1 targets ribosomal protein
  S6 kinase (S6K) and eukaryotic initiation factor 4E-binding protein 1 (4E-BP1),
  with the former directly effecting eukaryotic initiation factor 4E (eIF4E) and subsequent
  translation of cell cycle regulators.
papertitle: 'Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses,
  Drug Tolerance and Cellular Plasticity.'
reftext: Sarah Christine Elisabeth Wright, et al. Cancers (Basel). 2021 Apr;13(7):1538.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9627387
figid_alias: PMC8037590__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC8037590__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8037590__cancers-13-01538-g001.html
  '@type': Dataset
  description: The PI3K and MAPK signalling pathways. Growth factors and other external
    signalling molecules stimulate the activation of the PI3K and MAPK pathways through
    receptor tyrosine kinase (RTK) phosphorylation at the cell membrane. Activated
    RTKs recruit molecules bearing phosphotyrosine-binding (PTB) or Src homology-2
    (SH2) domains, such as IRS or p85, respectively. For PI3K enzymes, the binding
    of the p85 subunit activates the catalytic function of p110, prompting the phosphorylation
    of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) to phosphatidylinositol 3,4,5-trisphosphate
    (PI(3,4,5)P3). PI(3,4,5)P3, a prominent second messenger in cell signalling, accumulates
    at the cell membrane attracting molecules with pleckstrin-homology (PH) domains,
    primarily phosphoinositide-dependent protein kinase 1 (PDK1) and the AKT serine/threonine
    kinase family (protein kinase B/PKB). PDK1 partially activates AKT at threonine
    308 through phosphorylation, with full activation enabled by serine 473 phosphorylation
    via the mammalian target of rapamycin (mTOR) complex 2 (mTORC2). AKT targets various
    proteins in order to alter major signalling pathways within the cell. These include
    prosurvival pathways (BIM, BAX, BAD, BCL-2, MDM2 and FoxO1), cell cycle progression
    and glucose metabolism (p27, GSK3 and AS160), and cellular proliferation and protein
    synthesis (TSC2). Another prominent effector targeted downstream in the PI3K pathway
    is mTOR complex 1 (mTORC1), which has been shown to regulate cellular growth and
    metabolism, amongst other processes. In particular, mTORC1 targets ribosomal protein
    S6 kinase (S6K) and eukaryotic initiation factor 4E-binding protein 1 (4E-BP1),
    with the former directly effecting eukaryotic initiation factor 4E (eIF4E) and
    subsequent translation of cell cycle regulators.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tie
  - Ras85D
  - InR
  - Pdk1
  - Sos
  - Pten
  - Akt
  - rictor
  - Mtor
  - Tor
  - Lst8
  - drk
  - IRSp53
  - IleRS
  - chico
  - l(1)G0020
  - Taf4
  - Pi3K92E
  - Rpn2
  - Sap-r
  - Myb
  - Pi3K21B
  - Taf5
  - ras
  - Ras64B
  - Pi3K59F
  - Pi3K68D
  - Tsc1
  - gig
  - Rheb
  - Raf
  - sgg
  - Glut1
  - PRAS40
  - Bx
  - Dsor1
  - Mtk
  - DCTN6-p27
  - dap
  - CG9588
  - norpA
  - Pka-C1
  - raptor
  - Debcl
  - CycE
  - cyc
  - Crtc
  - rl
  - foxo
  - cass
  - S6k
  - Thor
  - p53
  - betaTub60D
  - hth
  - S6kII
  - RpS6
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - SLC2A4
  - SERPINA4
  - PDK1
  - PDPK1
  - XYLT2
  - SOS1
  - SOS2
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - RICTOR
  - DEPTOR
  - MTOR
  - MLST8
  - GRB2
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - CUX1
  - SART3
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - MTG1
  - MAPKAP1
  - TSC1
  - CCL26
  - TSC2
  - TBC1D4
  - RHEB
  - RHEBP1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - BCL2L11
  - GSK3A
  - GSK3B
  - SLC2A1
  - AKT1S1
  - BAX
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - BCL2
  - MDM2
  - RPTOR
  - MAPK3
  - MAPK1
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - BAD
  - RPS6KB1
  - EIF4EBP1
  - TP53
  - TP63
  - TP73
  - KMT2D
  - RPS6KA3
  - RPS6KA6
  - RPS6KA1
  - RPS6KA2
  - RPS6
  - EIF4E
  - EIF4E2
  - EIF4E3
  - GBL
  - GDP
---
